Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 3/20 | 0.47 |
| ▸ | CD38 | P28907 | 11/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.39 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.39 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.36 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.36 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16159862 | 1.00 | PIM1 (0.47) | PIM1CD38DYRK1AKDRPIK3CA | |
| SCHEMBL16159861 | 0.98 | PIM1 (0.46) | PIM1CD38DYRK1AKDRPIK3CA | |
| SCHEMBL16159860 | 0.98 | PIM1 (0.46) | PIM1CD38DYRK1AKDRPIK3CA | |
| SCHEMBL17704426 | 0.92 | PIM1 (0.45) | PIM1CD38DYRK1AKDRPIK3CA | |
| SCHEMBL17704441 | 0.91 | PIM1 (0.51) | PIM1CD38DYRK1AKDRPIK3CA | |
| SCHEMBL16159923 | 0.91 | PIM1 (0.51) | PIM1CD38DYRK1AKDRPIK3CA | |
| SCHEMBL16159308 | 0.91 | DYRK1A (0.47) | PIM1CD38DYRK1AKDRDYRK2 | |
| SCHEMBL17704423 | 0.89 | PIM1 (0.40) | PIM1CD38DYRK1ADYRK2DYRK1B | |
| SCHEMBL16159564 | 0.89 | PIM1 (0.49) | PIM1CD38DYRK1AKDRPIK3CA | |
| SCHEMBL16159859 | 0.88 | PIM1 (0.37) | PIM1CD38DYRK1APIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160118598-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | JNC CORPORATION (JP) | 2016-04-28 | — | — | US | disclosed |
| US-20160118598-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | JNC CORPORATION (JP) | 2016-04-28 | — | — | US | disclosed |
| WO-2014163173-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | JNC株式会社 (JP) | 2014-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160118598-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | HVCN1, VDAC1, SLC26A3 | PIM1 2642/4885CD38 2387/4885DYRK1A 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.